How to Cite
Abstract
Cystic macular edema, also known as Irvine Gass syndrome, is a post-surgical macular edema, being the main cause of visual acuity loss after ophthalmic surgery. The patient presents with decreased visual acuity and metamorphopsia in 1-2% of cases. The peak incidence occurs on average 6 weeks after surgery, however subclinical cystic macular edema may be present in 30% of patients and is diagnosed by angiography or optical coherence tomography. Among the risk factors are those that produce post-surgical inflammation, or one can also consider the patients' own risk factors such as uveitis, diabetes mellitus, presence of epiretinal membrane or retinal vein occlusion. It can cause low visual acuity, metamorphopsia and anterior chamber cells. The diagnosis is made through the patient's clinic, by means of indirect ophthalmoscopy. The natural history is spontaneous resolution, but recovery may take weeks or months. Therapies are aimed at reducing the inflammation generated by the disease.
Keywords
References
Bellocq D, Mathis T, Voirin N, Bentaleb ZM, Sallit R, Denis P, et al. Incidence of Irvine Gass Syndrome after Phacoemulsification with Spectral-Domain Optical Coherence Tomography. Ocul Immunol Inflamm [Internet]. 2019;27(8):1224-31. Disponible en: https://doi.org/10.1080/09273948.2019.1634215
de Carvalho KA, Demachki NT, Provenzano C, Morterá M, Vanzan V. Cystoid macular edema secondary to intraocular lens sub-luxation and iris perforation by iol haptic. Rev Bras Oftalmol. 2020;79(4):270-2.
Perera Miniet E, Ramos López M, García Ferrer L, Hernández Martínez R, Hernández Silva JR. Efectividad de la dorzolamida en el tratamiento del edema quístico macular poscirugía de catarata. Rev Cuba Oftalmol. 2020;33(4):1-20.
Kodjikian L, Bellocq D, Bodaghi B. Management of Irvine-Gass syndrom. J Fr Ophtalmol [Internet]. 2017;40(9):788-92. Disponible en: http://dx.doi.org/10.1016/j.jfo.2017.09.001
Keilani C, Halalchi A, Wakpi Djeugue D, Regis A, Abada S. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases. ELSEVIER [Internet]. 2016;71(5):457-65. Disponible en: http://dx.doi.org/10.1016/j.therap.2016.01.009
López FG, Moreno JMR. PREVALENCIA E IMPLICACIONES EN UN ESTUDIO CON SD-OCT DEL EDEMA MACULAR QUÍSTICO PSEUDOFÁQUICO EN EL POSTOPERATORIO DE LA CIRUGÍA DE CATARATA. 2016.
GUARACHE DEGFEGFL. Prevalencia Del Edema Macular Cistoideo En Pacientes Adultos Intervenidos De Catarata Por La Técnica De Facoemulsificación. Saber. 2016;28(4):736-43.
Jakob-Girbig J, Hahner L, Meller D. Very late onset Irvine-Gass Syndrome. Der Ophthalmol. 2020;(September):1-5.
Llop SM, Gonzalez E, Emanuelli A. SPONTANEOUS CLOSURE OF A FULL-THICKNESS MACULAR HOLE SECONDARY TO IRVINE-GASS SYNDROME. Retin Cases Brief Rep. 2017;11(3):243-5.
Zenobio LAT, Casusol REA De. Características clínico epidemiológicas del edema macular cistoide asociado a ruptura de cápsula posterior durante cirugía de catarata en el periodo enero 2018 – diciembre 2018. 2019.
Marques JH, Abreu AC, Silva N, Meireles A, Pessoa B, Beirão JM. Fluocinolone acetonide 0.19 mg implant in patients with cystoid macular edema due to irvine–gass syndrome. Int Med Case Rep J. 2021;14:127-32.
Erden B, Çakır A, Aslan AC, Bölükbaşı S, Elçioğlu MN. The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome. Ocul Immunol Inflamm [Internet]. 2019;27(8):1235-41. Disponible en: https://doi.org/10.1080/09273948.2019.162078
Grzybowski A, Sikorski BL, Ascaso FJ, Huerva V. Pseudophakic cystoid macular edema: Update 2016. Clin Interv Aging. 2016;11:1221-9.
Navarro-Partida J, Jauregui-García GD, Altamirano-Vallejo JC, Acosta-González R, González-De la Rosa A, Armendáriz-Borunda J, et al. Novel triamcinolone acetonide-loaded liposomes topical formulation to prevent cystoid macular edema after femtosecond laser-assisted cataract surgery. Rev Mex Oftalmol. 2021;94(5):193-203.
Bellocq D, Pierre-Kahn V, Matonti F, Burillon C, Voirin N, Dot C, et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: The EPISODIC-2 study. Br J Ophthalmol. 2016;101(3):333-41.
Lin CJ, Tsai YY. USE OF AFLIBERCEPT FOR THE MANAGEMENT OF REFRACTORY PSEUDOPHAKIC MACULAR EDEMA IN IRVINE-GASS SYNDROME AND LITERATURE REVIEW. Retin Cases Br Reports. 2018;12(1):59-62.
Ministerio de Salud. Norma Nacional de Vacunación. Ministerio de Salud de Costa Rica. 2013.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Array